We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TP (RIFT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03186482
Recruitment Status : Completed
First Posted : June 14, 2017
Last Update Posted : February 12, 2018
Information provided by (Responsible Party):
St Stephens Aids Trust ( St. Stephens Clinical Research )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 10, 2018
Actual Study Completion Date : January 10, 2018